the formulations met expectations at Rs 4.98bn. Operating margin at 10.2% (vs estimated 17%)sawsequentialfallfrom16.6%inQ3,resultingin44%our/consensusmissonEBITDA atRs635mn.ThankstotaxreversalofRs190mnthatboostedcorePATtoRs377mn,which...